The combination of Tet1 with Oct4 generates high-quality mouse-induced pluripotent stem cells

Stem Cells

Volumn 33, Issue 3, 2015, Pages 686-698

  Chen, Jiayu ^a,b   Gao, Shaorong ^a,b,d   Gao, Yawei ^a,b   Huang, Hua ^c   Xu, Kai ^a   Chen, Xia ^a   Jiang, Yonghua ^b   Li, Hui ^b   Gao, Shuai ^b   Tao, Yu ^b   Wang, Hong ^a   Zhang, Yong ^a   Wang, Hailin ^c   Cai, Tao ^b  

^a TONGJI UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

^c RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

^d NONE   (China)

Author keywords

DNA demethylation; Induced pluripotent stem cells; Pluripotency; Tet1

Indexed keywords

5 METHYLCYTOSINE; ALKALINE PHOSPHATASE; CADHERIN; GENOMIC DNA; GROWTH DIFFERENTIATION FACTOR 3; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TET1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; ZFP42 PROTEIN; DNA BINDING PROTEIN; ONCOPROTEIN; POU5F1 PROTEIN, MOUSE; TET1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; DEMETHYLATION; IMMUNOFLUORESCENCE; KARYOTYPING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; CELL REPROGRAMMING TECHNIQUE; CYTOLOGY; FEMALE; GENETICS; MALE; METABOLISM; PREGNANCY; PROCEDURES; TRANSGENIC MOUSE;

MUS;

ANIMALS; CELLULAR REPROGRAMMING TECHNIQUES; DNA-BINDING PROTEINS; FEMALE; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE; MICE, TRANSGENIC; OCTAMER TRANSCRIPTION FACTOR-3; PREGNANCY; PROTO-ONCOGENE PROTEINS;

EID: 84923217903     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1879     Document Type: Article

References (49)

1. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007; 448: 318-324.
2. Okita K, Ichisaka T, Yamanaka S,. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448: 313-317.
3. Maherali N, Sridharan R, Xie W, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007; 1: 55-70.
4. Takahashi K, Yamanaka S,. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
5. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
6. Kim JB, Sebastiano V, Wu G, et al. Oct4-induced pluripotency in adult neural stem cells. Cell 2009; 136: 411-419.
7. Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7: 618-630.
8. Carey BW, Markoulaki S, Hanna JH, et al. Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 2011; 9: 588-598.
9. Tsai SY, Bouwman BA, Ang YS, et al. Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells. Stem Cells 2011; 29: 964-971.
10. Wu T, Wang H, He J, et al. Reprogramming of trophoblast stem cells into pluripotent stem cells by Oct4. Stem Cells 2011; 29: 755-763.
11. Stadtfeld M, Apostolou E, Ferrari F, et al. Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nat Genet 2012; 44: 398-405, S391-392.
12. Boland MJ, Hazen JL, Nazor KL, et al. Adult mice generated from induced pluripotent stem cells. Nature 2009; 461: 91-94.
13. Zhao XY, Li W, Lv Z, et al. iPS cells produce viable mice through tetraploid complementation. Nature 2009; 461: 86-90.
14. Kang L, Wang J, Zhang Y, et al. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 2009; 5: 135-138.
15. Kang L, Wu T, Tao Y, et al. Viable mice produced from three-factor induced pluripotent stem (iPS) cells through tetraploid complementation. Cell Res 2011; 21: 546-549.
16. Stadtfeld M, Apostolou E, Akutsu H, et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010; 465: 175-181.
17. Wernig M, Meissner A, Cassady JP, et al. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008; 2: 10-12.
18. Stadtfeld M, Maherali N, Borkent M, et al. A reprogrammable mouse strain from gene-targeted embryonic stem cells. Nat Methods 2010; 7: 53-55.
19. Haffner MC, Chaux A, Meeker AK, et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2011; 2: 627-637.
20. Yang H, Liu Y, Bai F, et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2013; 32: 663-669.
21. Ko M, Huang Y, Jankowska AM, et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010; 468: 839-843.
22. Kudo Y, Tateishi K, Yamamoto K, et al. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci 2012; 103: 670-676.
23. Lian CG, Xu Y, Ceol C, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012; 150: 1135-1146.
24. Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324: 930-935.
25. Ito S, D'Alessio AC, Taranova OV, et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010; 466: 1129-1133.
26. Williams K, Christensen J, Pedersen MT, et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011; 473: 343-348.
27. Wu H, D'Alessio AC, Ito S, et al. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 2011; 473: 389-393.
28. Ficz G, Branco MR, Seisenberger S, et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011; 473: 398-402.
29. Xu Y, Wu F, Tan L, et al. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 2011; 42: 451-464.
30. Doege CA, Inoue K, Yamashita T, et al. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 2012; 488: 652-655.
31. Gao Y, Chen J, Li K, et al. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell 2013; 12: 453-469.
32. Costa Y, Ding J, Theunissen TW, et al. NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. Nature 2013; 495: 370-374.
33. Li Y, Zhang Q, Yin X, et al. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res 2011; 21: 196-204.
34. de Hoon MJ, Imoto S, Nolan J, et al. Open source clustering software. Bioinformatics 2004; 20: 1453-1454.
35. Yin R, Mao SQ, Zhao B, et al. Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J Am Chem Soc 2013; 135: 10396-10403.
36. Zhao B, Yang Y, Wang X, et al. Redox-active quinones induces genome-wide DNA methylation changes by an iron-mediated and Tet-dependent mechanism. Nucleic Acids Res 2014; 42: 1593-1605.
37. Kou Z, Kang L, Yuan Y, et al. Mice cloned from induced pluripotent stem cells (iPSCs). Biol Reprod 2010; 83: 238-243.
38. Yuan X, Wan H, Zhao X, et al. Brief report: Combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts. Stem Cells 2011; 29: 549-553.
39. Chen J, Liu J, Yang J, et al. BMPs functionally replace Klf4 and support efficient reprogramming of mouse fibroblasts by Oct4 alone. Cell Res 2011; 21: 205-212.
40. Nagy A, Rossant J, Nagy R, et al. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci USA 1993; 90: 8424-8428.
41. Nagy A, Gocza E, Diaz EM, et al. Embryonic stem cells alone are able to support fetal development in the mouse. Development 1990; 110: 815-821.
42. Wu G, Liu N, Rittelmeyer I, et al. Generation of healthy mice from gene-corrected disease-specific induced pluripotent stem cells. PLoS Biol 2011; 9: e1001099.
43. Kim K, Doi A, Wen B, et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010; 467: 285-290.
44. Polo JM, Liu S, Figueroa ME, et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010; 28: 848-855.
45. Hockemeyer D, Soldner F, Cook EG, et al. A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell 2008; 3: 346-353.
46. Samavarchi-Tehrani P, Golipour A, David L, et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010; 7: 64-77.
47. Jiao J, Dang Y, Yang Y, et al. Promoting reprogramming by FGF2 reveals that the extracellular matrix is a barrier for reprogramming fibroblasts to pluripotency. Stem Cells 2013; 31: 729-740.
48. Li R, Liang J, Ni S, et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010; 7: 51-63.
49. Lin Z, Perez P, Lei D, et al. Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction. Stem Cells 2011; 29: 1963-1974.